Varex Imaging Corp income statement
In fiscal 2025, Varex Imaging Corp reported revenue of $845m, up 4.1% on the year before, operating income of −$27.8m (a -3.3% margin) and net income of −$70.3m, or −$1.70 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2015Oct 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Oct 2020 | 2021Oct 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Oct 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 632 | 620 | 698 | 773 | 781 | 738 | 818 | 859 | 893 | 811 | 845 | 865 |
| Cost of revenue | 382 | 372 | 445 | 520 | 524 | 548 | 547 | 576 | 603 | 554 | 554 | 568 |
| Gross profit | 251 | 248 | 254 | 254 | 257 | 190 | 272 | 284 | 290 | 257 | 291 | 297 |
| Research and development | 50 | 54 | 67 | 83 | 78 | 79 | 72 | 77 | 85 | 87 | 91 | 91 |
| Selling, general and administrative | 73 | 86 | 103 | 123 | 128 | 142 | 126 | 118 | 128 | 138 | 133 | 133 |
| Operating income | 128 | 109 | 84 | 45 | 46 | −34 | 74 | 88 | 77 | 32 | −28 | 72 |
| Interest expense | 1 | 2 | 12 | 22 | 21 | 31 | 42 | 40 | 29 | 30 | 36 | 39 |
| Income before tax | 128 | 105 | 75 | 26 | 22 | −73 | 29 | 45 | 31 | 5 | −59 | 28 |
| Income tax | 47 | 36 | 23 | −3 | 6 | −15 | 11 | 14 | −17 | 53 | 11 | 5 |
| Net income | 80 | 69 | 52 | 28 | 16 | −58 | 17 | 30 | 47 | −49 | −70 | 22 |
| Diluted EPS | $2.12 | $1.82 | $1.36 | $0.72 | $0.40 | −$1.49 | $0.43 | $0.73 | $1.07 | −$1.20 | −$1.70 | $0.56 |
| Diluted shares (average) | 38m | 38m | 38m | 38m | 39m | 39m | 40m | 42m | 50m | 41m | 41m | 40m |
| EBITDA | 137 | 119 | 101 | 71 | 69 | −11 | 95 | 107 | 97 | 53 | −5 | 95 |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Jan 2025 | 2025 Q2Apr 2025 | 2025 Q3Jul 2025 | 2025 Q4Oct 2025 | 2026 Q1Jan 2026 | 2026 Q2Apr 2026 | 2026 Q3Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 206 | 200 | 213 | 203 | 229 | 210 | 216 | 211 |
| Cost of revenue | 139 | 131 | 136 | 136 | 151 | 140 | 143 | 134 |
| Gross profit | 67 | 69 | 77 | 68 | 78 | 70 | 73 | 77 |
| Research and development | 22 | 24 | 22 | 21 | 24 | 22 | 22 | 23 |
| Selling, general and administrative | 34 | 34 | 33 | 33 | 34 | 33 | 36 | 31 |
| Operating income | 11 | 11 | 22 | −81 | 20 | 15 | 14 | 23 |
| Interest expense | 8 | 8 | 10 | 9 | 8 | 8 | 17 | 6 |
| Income before tax | 3 | 3 | 11 | −87 | 14 | 4 | −6 | 16 |
| Income tax | 54 | 3 | 4 | 3 | 2 | 1 | 2 | 0 |
| Net income | −51 | −0 | 7 | −89 | 12 | 2 | −8 | 16 |
| Diluted EPS | −$1.26 | −$0.01 | $0.17 | −$2.15 | $0.30 | $0.05 | −$0.19 | $0.37 |
| EBITDA | 17 | 17 | 28 | −75 | 25 | 21 | 20 | 29 |
Compare with peers
- Inspire Medical Systems, Inc. income statement
- Alphatec Holdings, Inc. income statement
- Orthofix Medical Inc. income statement
- Irhythm Holdings, Inc. income statement
- Myriad Genetics Inc income statement
Head to head: INSP vs VREXATEC vs VREXOFIX vs VREX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies